Ligand validation:4YSX

EPH: L-ALPHA-PHOSPHATIDYL-BETA-OLEOYL-GAMMA-PALMITOYL-PHOSPHATIDYLETHANOLAMINE

EPH is a Ligand Of Interest in 4YSX designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4YSX_EPH_D_201	34%	41%	0.182	0.886	1.13	1.18	2	4	2	0	90%	0.898
4YSX_EPH_H_201	11%	40%	0.258	0.796	1.17	1.18	2	4	1	0	90%	0.898
3VRB_EPH_D_201	34%	12%	0.227	0.932	1.83	2.28	9	5	5	0	90%	0.898
4YTM_EPH_D_201	33%	45%	0.216	0.916	1.11	1.01	2	4	1	0	90%	0.898
4YSZ_EPH_D_201	31%	43%	0.209	0.895	1.11	1.11	2	4	0	0	90%	0.898
4YSY_EPH_D_201	24%	43%	0.257	0.904	1.13	1.07	2	4	0	0	90%	0.898
3VR8_EPH_D_201	22%	10%	0.241	0.879	1.88	2.4	8	5	6	0	90%	0.898
4ONI_EPH_A_601	63%	46%	0.144	0.939	1.01	1.08	2	3	2	0	100%	1
5Z9O_EPH_B_402	61%	42%	0.167	0.965	1.05	1.2	3	4	9	0	96%	0.9592
4DOR_EPH_B_601	49%	46%	0.158	0.912	0.98	1.12	2	5	9	0	96%	0.9592

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.